Billy buys HAS 52.46: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) May Not Be A Bad Bet In The Current Scenario
Most biotech stocks have recovered, at least to some extent, during the overall stock marketâs most recent run to new highs. However, some havenât. Wall Street has been betting heavily against Arena Pharmaceuticals, Inc.(NASDAQ:ARNA). Arena is one of . ... ...
44 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home